156 related articles for article (PubMed ID: 28659026)
1. Colonization and infection with extended-spectrum beta-lactamase producing Enterobacteriaceae in patients with malignancy.
Alevizakos M; Mylonakis E
Expert Rev Anti Infect Ther; 2017 Jul; 15(7):653-661. PubMed ID: 28659026
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcomes and prognostic factors in bloodstream infections due to extended-spectrum β-lactamase-producing Enterobacteriaceae among patients with malignancy: a meta-analysis.
Jiang AM; Liu N; Zhao R; Zheng HR; Chen X; Fan CX; Zhang R; Zheng XQ; Fu X; Yao Y; Tian T
Ann Clin Microbiol Antimicrob; 2020 Nov; 19(1):53. PubMed ID: 33228668
[TBL] [Abstract][Full Text] [Related]
3. Bloodstream infections due to extended-spectrum β-lactamase-producing Enterobacteriaceae among patients with malignancy: a systematic review and meta-analysis.
Alevizakos M; Gaitanidis A; Andreatos N; Arunachalam K; Flokas ME; Mylonakis E
Int J Antimicrob Agents; 2017 Nov; 50(5):657-663. PubMed ID: 28705665
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and risk factors of infections caused by extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae.
Nakai H; Hagihara M; Kato H; Hirai J; Nishiyama N; Koizumi Y; Sakanashi D; Suematsu H; Yamagishi Y; Mikamo H
J Infect Chemother; 2016 May; 22(5):319-26. PubMed ID: 26968486
[TBL] [Abstract][Full Text] [Related]
5. Extended-spectrum β-lactamase-producing Enterobacteriaceae in children: old foe, emerging threat.
Lukac PJ; Bonomo RA; Logan LK
Clin Infect Dis; 2015 May; 60(9):1389-97. PubMed ID: 25595742
[TBL] [Abstract][Full Text] [Related]
6. Colonization and infection with extended-spectrum β-lactamase-producing Enterobacteriaceae in ICU patients: what impact on outcomes and carbapenem exposure?
Barbier F; Pommier C; Essaied W; Garrouste-Orgeas M; Schwebel C; Ruckly S; Dumenil AS; Lemiale V; Mourvillier B; Clec'h C; Darmon M; Laurent V; Marcotte G; Lucet JC; Souweine B; Zahar JR; Timsit JF;
J Antimicrob Chemother; 2016 Apr; 71(4):1088-97. PubMed ID: 26755492
[TBL] [Abstract][Full Text] [Related]
7. Colonisation with extended-spectrum β-lactamase-producing Enterobacteriaceae and risk for infection among patients with solid or haematological malignancy: a systematic review and meta-analysis.
Alevizakos M; Karanika S; Detsis M; Mylonakis E
Int J Antimicrob Agents; 2016 Dec; 48(6):647-654. PubMed ID: 27746102
[TBL] [Abstract][Full Text] [Related]
8. High levels of antimicrobial coresistance among extended-spectrum-beta-lactamase-producing Enterobacteriaceae.
Schwaber MJ; Navon-Venezia S; Schwartz D; Carmeli Y
Antimicrob Agents Chemother; 2005 May; 49(5):2137-9. PubMed ID: 15855548
[TBL] [Abstract][Full Text] [Related]
9. Bloodstream infection with extended-spectrum beta-lactamase-producing Enterobacteriaceae at a tertiary care hospital in New Zealand: risk factors and outcomes.
Freeman JT; McBride SJ; Nisbet MS; Gamble GD; Williamson DA; Taylor SL; Holland DJ
Int J Infect Dis; 2012 May; 16(5):e371-4. PubMed ID: 22401750
[TBL] [Abstract][Full Text] [Related]
10. Colonization with extended-spectrum beta-lactamase-producing and carbapenemase-producing Enterobacteriaceae in international travelers returning to Germany.
Lübbert C; Straube L; Stein C; Makarewicz O; Schubert S; Mössner J; Pletz MW; Rodloff AC
Int J Med Microbiol; 2015 Jan; 305(1):148-56. PubMed ID: 25547265
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for colonization with extended-spectrum beta-lactamase-producing enterobacteriaceae on admission to rehabilitation centres.
Bilavsky E; Temkin E; Lerman Y; Rabinovich A; Salomon J; Lawrence C; Rossini A; Salvia A; Samso JV; Fierro J; Paul M; Hart J; Gniadkowski M; Hochman M; Kazma M; Klein A; Adler A; Schwaber MJ; Carmeli Y;
Clin Microbiol Infect; 2014 Nov; 20(11):O804-10. PubMed ID: 24674024
[TBL] [Abstract][Full Text] [Related]
12. Extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) among travellers to Africa: destination-specific data pooled from three European prospective studies.
Lääveri T; Vlot JA; van Dam AP; Häkkinen HK; Sonder GJB; Visser LG; Kantele A
BMC Infect Dis; 2018 Jul; 18(1):341. PubMed ID: 30037325
[TBL] [Abstract][Full Text] [Related]
13. Molecular characteristics of extended-spectrum β-lactamases in clinical isolates of Enterobacteriaceae from the Philippines.
Kanamori H; Navarro RB; Yano H; Sombrero LT; Capeding MR; Lupisan SP; Olveda RM; Arai K; Kunishima H; Hirakata Y; Kaku M
Acta Trop; 2011; 120(1-2):140-5. PubMed ID: 21820398
[TBL] [Abstract][Full Text] [Related]
14. Multidrug-resistant ESBL-producing Enterobacteriaceae and associated risk factors in community infants in Lebanon.
Hijazi SM; Fawzi MA; Ali FM; Abd El Galil KH
J Infect Dev Ctries; 2016 Sep; 10(9):947-955. PubMed ID: 27694727
[TBL] [Abstract][Full Text] [Related]
15. Rate of transmission of extended-spectrum beta-lactamase-producing enterobacteriaceae without contact isolation.
Tschudin-Sutter S; Frei R; Dangel M; Stranden A; Widmer AF
Clin Infect Dis; 2012 Dec; 55(11):1505-11. PubMed ID: 22955436
[TBL] [Abstract][Full Text] [Related]
16. Characterisation of extended-spectrum β-lactamase and AmpC β-lactamase-producing Enterobacteriaceae isolated from companion animals in New Zealand.
Karkaba A; Grinberg A; Benschop J; Pleydell E
N Z Vet J; 2017 Mar; 65(2):105-112. PubMed ID: 27973988
[TBL] [Abstract][Full Text] [Related]
17. Fecal Colonization With Extended-spectrum Beta-lactamase-Producing Enterobacteriaceae and Risk Factors Among Healthy Individuals: A Systematic Review and Metaanalysis.
Karanika S; Karantanos T; Arvanitis M; Grigoras C; Mylonakis E
Clin Infect Dis; 2016 Aug; 63(3):310-8. PubMed ID: 27143671
[TBL] [Abstract][Full Text] [Related]
18. Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment.
Tumbarello M; Sanguinetti M; Montuori E; Trecarichi EM; Posteraro B; Fiori B; Citton R; D'Inzeo T; Fadda G; Cauda R; Spanu T
Antimicrob Agents Chemother; 2007 Jun; 51(6):1987-94. PubMed ID: 17387156
[TBL] [Abstract][Full Text] [Related]
19. Geographic mapping of Enterobacteriaceae with extended-spectrum β-lactamase (ESBL) phenotype in Pereira, Colombia.
Arias Ramos D; Hoyos Pulgarín JA; Moreno Gómez GA; Alzate JA; Olaya Gómez JC; Cortés Bonilla I; Vargas Mosquera C
BMC Infect Dis; 2020 Jul; 20(1):540. PubMed ID: 32703276
[TBL] [Abstract][Full Text] [Related]
20. Current status of extended spectrum β-lactamase-producing Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis in Okinawa prefecture, Japan.
Nakama R; Shingaki A; Miyazato H; Higa R; Nagamoto C; Hamamoto K; Ueda S; Hachiman T; Touma Y; Miyagi K; Kawahara R; Toyosato T; Hirai I
J Infect Chemother; 2016 May; 22(5):281-6. PubMed ID: 26898665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
